Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




Surgical Myotomy Recommended for Achalasia

By HospiMedica staff writers
Posted on 13 Dec 2006
Achalasia managed by surgical myotomy is less likely to require subsequent treatments compared with pneumatic dilatation, according to new findings.

Researchers from the University of Toronto (Canada) evaluated the outcomes of both surgical myotomy and pneumatic dilatation by linking records from several Ontario (Canada) health databases for the period between 1991-2002. More...
The 1,461 subjects that were over the age of 18 were followed on average for five years. Outcome was defined as the need for a subsequent intervention--pneumatic dilatation, myotomy, or esophageal resection.

Among the 1,181 adult patients who underwent pneumatic dilatation, 36.8% required another intervention within the first year of follow-up, and 56.2% required the same during five years of follow-up. Corresponding rates for the 280 patients treated with surgical myotomy were 16.4% and 36.8%. After adjustment for age, gender, comorbidity, and income status, initial treatment with pneumatic dilatation was significantly more likely than surgery to require another intervention. The results were published in the November 8, 2006, issue of the Journal of the American Medical Association (JAMA).

"Persons with achalasia should be aware of the long-term effectiveness of pneumatic dilatation and surgical myotomy in average practice settings,” concluded authors Dr. Steven R. Lopushinsky and Dr. David R. Urbach, of the University of Toronto. They also advised patients and their physicians to consider the risks of the procedures, the ability of doctors to improve symptoms, the risk of gastroesophageal reflex, as well as costs associated with the longer hospital stay after surgery.

Achalasia is the failure of a ring of muscle (such as a sphincter) to relax. Any smooth muscle fibers at any junction of the gastrointestinal tract such as the pylorus, cardia, or other sphincter muscles can be involved, but the term most commonly refers to esophageal achalasia, a disorder of the esophagus that does not allow food to pass to the stomach.



Related Links:
University of Toronto

Gold Member
Real-Time Diagnostics Onscreen Viewer
GEMweb Live
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Half Apron
Demi
Head Rest
Medifa 61114_3
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Critical Care

view channel
Image: The researchers grew pancreatic tissue (above) so it incorporated a mesh-like electronic network (red). Cells within the tissue produce insulin (green). (Photo courtesy of Penn Medicine)

‘Cyborg’ Transplants Could Replace Pancreatic Tissue Damaged by Diabetes

Type 1 diabetes destroys insulin-producing islet cells, forcing patients to rely on lifelong insulin therapy or scarce organ transplants. Although lab-grown pancreatic tissue offers a promising alternative,... Read more

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.